| Trial name or title |
A randomized control trial of anticoagulation and inferior vena cava filters in cancer patients with a venous thromboembolism. |
| Methods |
Study design: Randomized, open label, active control, parallel assignment, safety/efficacy study. |
| Participants |
Cancer patients, over 18 years of age, acute radiographically confirmed denovo DVT or PE. |
| Interventions |
Arixtra (fondaparinux) alone vs. arixtra with filter. |
| Outcomes |
Primary outcomes: Death due to any cause, event free survival.
Secondary outcomes: Occurrence of pulmonary embolism, major bleeding, thrombophlebitis, cellulitis secondary to IV filter, thrombosis of the IVC filter and quality of life. |
| Starting date |
January 2007 |
| Contact information |
Myra Barginear, MD |
| Notes |
NCT00423683 |
